Influence of Melanoma Type on Incidence and Downstream Implications of Cutaneous Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy
J Am Acad Dermatol 2023 Feb 22;[EPub Ahead of Print], N Nguyen, G Wan, P Ugwu-Dike, NA Alexander, N Raval, S Zhang, R Jairath, J Phillipps, B Leung, K Roster, J Seo, C Lu, K Tang, MS Choi, MS DeSimone, N Theodosakis, M Amadife, N Cox, TK Le, F Liu, W Chen, X Bai, G Boland, D Liu, MS Hurlbert, N LeBoeuf, KL Reynolds, KH Yu, H Tsao, M Asgari, A Gusev, SG Kwatra, YR SemenovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.